New radiation technique for brain tumors under the microscope
NCT ID NCT05270707
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study gathered information from nearly 1,000 patients who received or were scheduled to receive HyperArc stereotactic radiosurgery, a precise radiation treatment for brain tumors. The goal was to collect data on survival and tumor control to compare HyperArc with other treatments. The study did not test a new drug but aimed to understand how well this radiation technique works in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HyperArc stereotactic radiosurgery (a precise radiation treatment for brain tumors)
What this could lead to
If the data show HyperArc is effective, it could support its use as a standard treatment for brain metastases.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Icon Cancer Centre Canberra
Bruce, Australian Capital Territory, 2617, Australia
-
Icon Cancer Centre Gold Coast Private
Southport, Queensland, 4215, Australia
-
Icon Cancer Centre Greenslopes
Greenslopes, Queensland, 4120, Australia
-
Icon Cancer Centre Maroochydore
Maroochydore, Queensland, 4558, Australia
-
L'IRCCS Ospedale Sacro Cuore - Don Calabria
Negrar, Valpolicella, 37024, Italy
-
University Hospital Leuven
Leuven, 3000, Belgium
-
University of Alabama
Birmingham, Alabama, 35233, United States